East Region Formulary
NHS Scotland

Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Vildagliptin + Metformin
Eucreas
Not routinely available
SMC (874/13)
13/05/2013

Indication

Treatment of type 2 diabetes mellitus: in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulphonylurea - in triple combination therapy with insulin as an adjunct to diet and exercise to im...

Treatment of type 2 diabetes mellitus: in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulphonylurea - in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.

Therapeutic Area

Endocrine system

Status Description

Not routinely available as not recommended for use in NHSScotland

Formulation

50mg/850mg and 50mg/1000mg film-coated tablets

Comments

None

Link to Advice

874/13

Advice Published

13/05/2013

SMC Submission Type

Non submission

SMC Status

Not recommended